FDA.reportPublic FDA data

DPH sodium 30 MG Extended Release Oral Capsule

RxCUI
855869
RxNorm name
DPH sodium 30 MG Extended Release Oral Capsule
Display name
DPH sodium 30 MG Extended Release Oral Capsule
Full name
DPH sodium 30 MG Extended Release Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DILANTINEXTENDED PHENYTOIN SODIUMREMEDYREPACK INC.db8c69b0-4697-433e-98c7-b0b2d2c52a832025-10-02Warnings, Adverse reactionsExact identifier
rxcui: 855869
DILANTINEXTENDED PHENYTOIN SODIUMViatris Specialty LLC86dd27d1-9cee-48ae-b55d-e2d2f7dbc5932023-08-21Warnings, Adverse reactionsExact identifier
rxcui: 855869

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 5 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4f918d15-908e-4c3a-94d6-71370da9a116phenytoin sodium 30 MG Extended Release Oral Capsule [PSN] · phenytoin sodium 30 MG Extended Release Oral Capsule [SCD] · DPH sodium 30 MG Extended Release Oral Capsule [SY]34These highlights do not include all the information needed to use DILANTIN ® safely and effectively. See full prescribing information for DILANTIN ® . DILANTIN ® (phenytoin sodium) Extended Capsules, for oral use Initial U.S. Approval: 195320170706
86dd27d1-9cee-48ae-b55d-e2d2f7dbc593phenytoin sodium 30 MG Extended Release Oral Capsule [PSN] · phenytoin sodium 30 MG Extended Release Oral Capsule [SCD] · DPH sodium 30 MG Extended Release Oral Capsule [SY]33These highlights do not include all the information needed to use DILANTIN ® safely and effectively. See full prescribing information for DILANTIN ® . DILANTIN ® (extended phenytoin sodium capsules), for oral use Initial U.S. Approval: 195320230821
db8c69b0-4697-433e-98c7-b0b2d2c52a83phenytoin sodium 30 MG Extended Release Oral Capsule [PSN] · phenytoin sodium 30 MG Extended Release Oral Capsule [SCD] · DPH sodium 30 MG Extended Release Oral Capsule [SY]32These highlights do not include all the information needed to use DILANTIN ® safely and effectively. See full prescribing information for DILANTIN ® . DILANTIN ® (extended phenytoin sodium capsules), for oral use Initial U.S. Approval: 195320251002
1fd75c5a-f56b-42a2-aa4a-9cd0344d0a6fphenytoin sodium 30 MG Extended Release Oral Capsule [PSN] · phenytoin sodium 30 MG Extended Release Oral Capsule [SCD] · DPH sodium 30 MG Extended Release Oral Capsule [SY]32Dilantin ® (Extended Phenytoin Sodium Capsules, USP)20100304
5554a280-0490-4235-9c8c-bea141db6884phenytoin sodium 30 MG Extended Release Oral Capsule [PSN] · phenytoin sodium 30 MG Extended Release Oral Capsule [SCD] · DPH sodium 30 MG Extended Release Oral Capsule [SY]31Dilantin ® (extended phenytoin sodium capsules, USP)20151203